Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics
Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmis...
Saved in:
Published in | PLoS computational biology Vol. 17; no. 3; p. e1008688 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
09.03.2021
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation, where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. |
---|---|
AbstractList | Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation, where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. [...]our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. [...]the large amount of PCR tests that is required to facilitate this approach, remains an important impediment. [...]we propose a new universal testing procedure that is feasible with the current testing capacity, where we rely on PCR test pooling of individuals that belong to the same households. [...]pool isolation, where we isolate all individuals that belong to a positive PCR test pool, regardless of their individual infection status. [...]individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation , where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation , where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. [...]our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. [...]the large amount of PCR tests that is required to facilitate this approach, remains an important impediment. [...]we propose a new universal testing procedure that is feasible with the current testing capacity, where we rely on PCR test pooling of individuals that belong to the same households. [...]pool isolation, where we isolate all individuals that belong to a positive PCR test pool, regardless of their individual infection status. [...]individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation , where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation , where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. As pre-symptomatic transmission is an important driver of COVID-19 epidemics (i.e., the virus is transmitted before the infected individual is aware of its infection), contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. For this reason, the use of universal testing, where each individual of the community is tested on a regular basis, has been suggested. However, the large amount of PCR tests that is required to facilitate this approach, remains an important impediment. Therefore, we propose a new universal testing procedure that is feasible with the current testing capacity, where we rely on PCR test pooling of individuals that belong to the same households. We evaluate this universal testing procedure in a fine-grained epidemiological model (i.e., an individual-based model) that covers the Belgian population. Through this evaluation, we assess the procedure’s performance to keep the epidemic under control, while allowing for various contact reductions. We assess the robustness of the model, by analysing different levels of community compliance, and we show that weekly universal testing could prove a successful strategy to control SARS-CoV-2 outbreaks. |
Audience | Academic |
Author | Libin, Pieter J K Vanderlocht, Joris Hens, Niel Willem, Lander Torneri, Andrea Verstraeten, Timothy |
AuthorAffiliation | University of Notre Dame, UNITED STATES 3 KU Leuven – University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium 4 Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium 2 Artificial Intelligence Lab, Department of computer science, Vrije Universiteit Brussel, Brussels, Belgium 1 Interuniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium |
AuthorAffiliation_xml | – name: 3 KU Leuven – University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium – name: 2 Artificial Intelligence Lab, Department of computer science, Vrije Universiteit Brussel, Brussels, Belgium – name: 1 Interuniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium – name: 4 Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium – name: University of Notre Dame, UNITED STATES |
Author_xml | – sequence: 1 givenname: Pieter J K orcidid: 0000-0003-3906-758X surname: Libin fullname: Libin, Pieter J K organization: KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium – sequence: 2 givenname: Lander orcidid: 0000-0002-9210-1196 surname: Willem fullname: Willem, Lander organization: Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium – sequence: 3 givenname: Timothy orcidid: 0000-0003-3036-617X surname: Verstraeten fullname: Verstraeten, Timothy organization: Artificial Intelligence Lab, Department of computer science, Vrije Universiteit Brussel, Brussels, Belgium – sequence: 4 givenname: Andrea orcidid: 0000-0002-4322-0770 surname: Torneri fullname: Torneri, Andrea organization: Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium – sequence: 5 givenname: Joris orcidid: 0000-0003-1635-2791 surname: Vanderlocht fullname: Vanderlocht, Joris organization: Interuniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium – sequence: 6 givenname: Niel orcidid: 0000-0003-1881-0637 surname: Hens fullname: Hens, Niel organization: Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33690626$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkk2P2yAQhq1qq-5H-w-qFqmX9uDUGIzxpVKUfkVadaV-XRGGwSEikDX2qvvvSxLvalPtpeIAgmfeYd6Z8-zEBw9Z9hIXM0xq_H4dxt5LN9uq1s5wUXDG-ZPsDFcVyWtS8ZMH59PsPMZ1UaRjw55lp4SwpmAlO8vCPEaI0foODStABmS0rXV2uEXSawTGgBrsDfgEoWDQKowRVsHpfBuCA41Gn177KB0aIA57nYBU8EMfHFpc_V5-zHGDYGs1bKyKz7OnRroIL6b9Ivv1-dPPxdf88urLcjG_zBVjeMhJi6EuDZS0bduSUlwXgHXBGt6YqlAy7VS3ktTQAmu0IRoTzEvAppKKtCW5yF4fdLcuRDF5FUVZYcI4xRVPxPJA6CDXYtvbjexvRZBW7C9C3wnZD1Y5ELjRJaMKGqkbiiVveG24JopWXKXkO60PU7ax3YBWkMqX7kj0-MXblejCjagbSlJbksDbSaAP12MyUmxsVOCc9JAcT_9OFOeY4oS--Qd9vLqJ6mQqwHoTUl61ExVzVvEal4zRRM0eodLaNyvNm7Hp_ijg3VHArtHwZ-jkGKNY_vj-H-y3Y5YeWNWHGHsw997hQuzG_a5IsRt3MY17Cnv10Pf7oLv5Jn8BMon96A |
CitedBy_id | crossref_primary_10_7554_eLife_75593 crossref_primary_10_1016_j_eswa_2024_123686 crossref_primary_10_1016_j_mbs_2022_108805 crossref_primary_10_1038_s41598_021_01065_0 crossref_primary_10_1186_s12879_021_06092_w crossref_primary_10_1080_21655979_2021_1987821 crossref_primary_10_22207_JPAM_16_4_11 crossref_primary_10_1038_s41598_022_10128_9 crossref_primary_10_1098_rsif_2023_0087 crossref_primary_10_1016_j_jtbi_2023_111703 crossref_primary_10_1371_journal_pcbi_1009980 crossref_primary_10_1371_journal_pcbi_1008892 crossref_primary_10_1186_s12879_024_09007_7 crossref_primary_10_3389_fpubh_2022_757065 crossref_primary_10_3390_tropicalmed7110376 crossref_primary_10_1021_jacsau_1c00048 crossref_primary_10_3389_fmicb_2022_889643 crossref_primary_10_1016_j_epidem_2023_100701 crossref_primary_10_1371_journal_pcbi_1010008 crossref_primary_10_2196_44349 |
Cites_doi | 10.1101/2020.06.08.20125179 10.1101/2020.04.23.20077024 10.1098/rspb.2010.2688 10.1073/pnas.1911083116 10.1038/d41573-020-00016-0 10.1101/2020.07.18.20156307 10.1101/2020.02.08.20021162 10.1038/s41591-020-1036-8 10.1186/s12916-020-01636-4 10.1001/jama.2020.12603 10.1016/S0140-6736(20)30936-3 10.1016/S0140-6736(20)32261-3 10.1016/j.hrthm.2020.06.026 10.1137/0207001 10.1101/2020.06.22.20136309 10.1038/s41591-020-0869-5 10.1016/S1473-3099(20)30457-6 10.1038/s41591-020-0822-7 10.1101/2020.03.26.20039438 10.1101/2020.08.04.20167874 10.1371/journal.pone.0048695 10.1101/2020.06.29.20142851 10.1016/j.procs.2017.05.086 10.1371/journal.pone.0243692 10.1016/j.vaccine.2019.06.081 10.1016/S2213-2600(20)30222-8 10.1126/science.abb4218 10.1038/s41591-020-0962-9 10.2807/1560-7917.ES.2020.25.5.2000062 10.1056/NEJMp2005630 10.1126/sciadv.abd3083 10.1101/2020.04.27.20078329 10.1093/bib/bbaa232 10.1126/science.abc5798 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 Public Library of Science 2021 Libin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Libin et al 2021 Libin et al |
Copyright_xml | – notice: COPYRIGHT 2021 Public Library of Science – notice: 2021 Libin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Libin et al 2021 Libin et al |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISN ISR 3V. 7QO 7QP 7TK 7TM 7X7 7XB 88E 8AL 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU COVID DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ JQ2 K7- K9. LK8 M0N M0S M1P M7P P5Z P62 P64 PIMPY PQEST PQQKQ PQUKI PRINS Q9U RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pcbi.1008688 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Canada Gale in Context: Science ProQuest Central (Corporate) Biotechnology Research Abstracts Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Computing Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Computer Science Collection Computer Science Database ProQuest Health & Medical Complete (Alumni) Biological Sciences Computing Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Computer Science Database ProQuest Central Student Technology Collection Technology Research Database ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Computer Science Collection Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Genetics Abstracts Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Computing ProQuest Biological Science Collection ProQuest Central Basic ProQuest Computing (Alumni Edition) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Household-pooled universal testing to control COVID-19 epidemics |
EISSN | 1553-7358 |
Editor | Perkins, Alex |
Editor_xml | – sequence: 1 givenname: Alex surname: Perkins fullname: Perkins, Alex |
EndPage | e1008688 |
ExternalDocumentID | 2513684158 oai_doaj_org_article_19d264ce9ad941a8987f8d3c458c9df8 A658712664 10_1371_journal_pcbi_1008688 33690626 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Belgium |
GeographicLocations_xml | – name: Belgium |
GrantInformation_xml | – fundername: European Research Council |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ AAFWJ AAKPC ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ARAPS AZQEC B0M BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI BWKFM C1A CCPQU CGR CS3 CUY CVF DIK DWQXO E3Z EAP EAS EBD EBS ECM EIF EJD EMK EMOBN ESX F5P FPL FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IGS INH INR IPNFZ ISN ISR ITC J9A K6V K7- KQ8 LK8 M0N M1P M48 M7P M~E NPM O5R O5S OK1 P2P P62 PGMZT PIMPY PQQKQ PROAC PSQYO PV9 RIG RNS RPM RZL SV3 TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX AFPKN CITATION 7QO 7QP 7TK 7TM 7XB 8AL 8FD 8FK COVID FR3 JQ2 K9. P64 PQEST PQUKI PRINS Q9U RC3 7X8 5PM - AAPBV ABPTK ADACO BBAFP |
ID | FETCH-LOGICAL-c661t-3b1e72fe24bbb244170e1d06989f50ca9894dba37ebe69df3d13182e1f5ac3b23 |
IEDL.DBID | RPM |
ISSN | 1553-7358 1553-734X |
IngestDate | Fri Nov 26 17:11:57 EST 2021 Tue Oct 22 15:13:08 EDT 2024 Tue Sep 17 21:21:55 EDT 2024 Fri Oct 25 05:52:10 EDT 2024 Thu Oct 10 19:12:47 EDT 2024 Fri Feb 23 00:13:24 EST 2024 Fri Oct 18 02:35:25 EDT 2024 Thu Aug 01 19:27:19 EDT 2024 Fri Oct 18 02:33:28 EDT 2024 Fri Aug 23 00:47:43 EDT 2024 Wed Oct 16 00:43:38 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c661t-3b1e72fe24bbb244170e1d06989f50ca9894dba37ebe69df3d13182e1f5ac3b23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The authors have read the journal’s policy concerning competing interests. JV is, besides his employment at the Hasselt University, part of the investment team of Bioqube Ventures. Bioqube Ventures was not involved in this work, nor does it prosper financially as a result of the current study. The other authors declare that they have no competing interests. |
ORCID | 0000-0002-9210-1196 0000-0003-1635-2791 0000-0002-4322-0770 0000-0003-1881-0637 0000-0003-3036-617X 0000-0003-3906-758X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943003/ |
PMID | 33690626 |
PQID | 2513684158 |
PQPubID | 1436340 |
ParticipantIDs | plos_journals_2513684158 doaj_primary_oai_doaj_org_article_19d264ce9ad941a8987f8d3c458c9df8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7943003 proquest_miscellaneous_2500388141 proquest_journals_2513684158 gale_infotracmisc_A658712664 gale_infotracacademiconefile_A658712664 gale_incontextgauss_ISR_A658712664 gale_incontextgauss_ISN_A658712664 crossref_primary_10_1371_journal_pcbi_1008688 pubmed_primary_33690626 |
PublicationCentury | 2000 |
PublicationDate | 2021-03-09 |
PublicationDateYYYYMMDD | 2021-03-09 |
PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-09 day: 09 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PLoS computational biology |
PublicationTitleAlternate | PLoS Comput Biol |
PublicationYear | 2021 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | I Baptista (pcbi.1008688.ref048) 2019; 93 pcbi.1008688.ref033 Q Li (pcbi.1008688.ref034) 2020 P Spagnolo (pcbi.1008688.ref012) 2020; 8 A Torneri (pcbi.1008688.ref014) 2020; 18 EG Coffman (pcbi.1008688.ref026) 1978; 7 LM Kucirka (pcbi.1008688.ref039) 2020 JT Wu (pcbi.1008688.ref035) 2020; 26 E Lavezzo (pcbi.1008688.ref019) 2020 L Willem (pcbi.1008688.ref041) 2012; 7 pcbi.1008688.ref032 pcbi.1008688.ref027 A Sakurai (pcbi.1008688.ref002) 2020 pcbi.1008688.ref029 pcbi.1008688.ref028 pcbi.1008688.ref023 pcbi.1008688.ref022 NG Davies (pcbi.1008688.ref036) 2020; 26 AJ Kucharski (pcbi.1008688.ref037) 2020; 20 S Woloshin (pcbi.1008688.ref042) 2020 X He (pcbi.1008688.ref031) 2020; 26 pcbi.1008688.ref020 pcbi.1008688.ref016 pcbi.1008688.ref015 pcbi.1008688.ref018 pcbi.1008688.ref011 S Ozawa (pcbi.1008688.ref049) 2019; 37 pcbi.1008688.ref013 E Holt (pcbi.1008688.ref051) 2020; 396 JA Firth (pcbi.1008688.ref038) 2020; 26 pcbi.1008688.ref010 pcbi.1008688.ref053 L Willem (pcbi.1008688.ref021) 2020 pcbi.1008688.ref050 pcbi.1008688.ref005 pcbi.1008688.ref004 pcbi.1008688.ref007 pcbi.1008688.ref001 pcbi.1008688.ref045 pcbi.1008688.ref044 pcbi.1008688.ref047 pcbi.1008688.ref046 J Peto (pcbi.1008688.ref017) 2020; 368 S Nickbakhsh (pcbi.1008688.ref024) 2019; 116 pcbi.1008688.ref009 pcbi.1008688.ref008 T House (pcbi.1008688.ref025) 2011; 278 MU Kraemer (pcbi.1008688.ref006) 2020; 368 N Lurie (pcbi.1008688.ref003) 2020; 382 pcbi.1008688.ref040 JA Backer (pcbi.1008688.ref030) 2020; 25 pcbi.1008688.ref043 EP Fischer (pcbi.1008688.ref052) 2020 |
References_xml | – year: 2020 ident: pcbi.1008688.ref021 article-title: The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19: an individual-based modelling study publication-title: Nature Communications contributor: fullname: L Willem – ident: pcbi.1008688.ref033 doi: 10.1101/2020.06.08.20125179 – ident: pcbi.1008688.ref007 – ident: pcbi.1008688.ref015 doi: 10.1101/2020.04.23.20077024 – volume: 278 start-page: 2753 issue: 1719 year: 2011 ident: pcbi.1008688.ref025 article-title: Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic publication-title: Proceedings of the Royal Society B: Biological Sciences doi: 10.1098/rspb.2010.2688 contributor: fullname: T House – ident: pcbi.1008688.ref023 – volume: 116 start-page: 27142 issue: 52 year: 2019 ident: pcbi.1008688.ref024 article-title: Virus–virus interactions impact the population dynamics of influenza and the common cold publication-title: Proceedings of the National Academy of Sciences doi: 10.1073/pnas.1911083116 contributor: fullname: S Nickbakhsh – volume: 368 year: 2020 ident: pcbi.1008688.ref017 article-title: Covid-19 mass testing facilities could end the epidemic rapidly publication-title: BMJ contributor: fullname: J Peto – ident: pcbi.1008688.ref004 doi: 10.1038/d41573-020-00016-0 – ident: pcbi.1008688.ref032 doi: 10.1101/2020.07.18.20156307 – ident: pcbi.1008688.ref013 doi: 10.1101/2020.02.08.20021162 – volume: 26 start-page: 1616 issue: 10 year: 2020 ident: pcbi.1008688.ref038 article-title: Using a real-world network to model localized COVID-19 control strategies publication-title: Nature medicine doi: 10.1038/s41591-020-1036-8 contributor: fullname: JA Firth – volume: 18 start-page: 191 issue: 1 year: 2020 ident: pcbi.1008688.ref014 article-title: A prospect on the use of antiviral drugs to control local outbreaks of COVID-19 publication-title: BMC Medicine doi: 10.1186/s12916-020-01636-4 contributor: fullname: A Torneri – ident: pcbi.1008688.ref010 doi: 10.1001/jama.2020.12603 – ident: pcbi.1008688.ref016 doi: 10.1016/S0140-6736(20)30936-3 – ident: pcbi.1008688.ref008 – start-page: 1 year: 2020 ident: pcbi.1008688.ref019 article-title: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ publication-title: Nature contributor: fullname: E Lavezzo – ident: pcbi.1008688.ref029 – volume: 396 start-page: 1386 issue: 10260 year: 2020 ident: pcbi.1008688.ref051 article-title: Slovakia to test all adults for SARS-CoV-2 publication-title: The Lancet doi: 10.1016/S0140-6736(20)32261-3 contributor: fullname: E Holt – ident: pcbi.1008688.ref022 – ident: pcbi.1008688.ref011 doi: 10.1016/j.hrthm.2020.06.026 – ident: pcbi.1008688.ref001 – volume: 7 start-page: 1 issue: 1 year: 1978 ident: pcbi.1008688.ref026 article-title: An application of bin-packing to multiprocessor scheduling publication-title: SIAM Journal on Computing doi: 10.1137/0207001 contributor: fullname: EG Coffman – ident: pcbi.1008688.ref043 doi: 10.1101/2020.06.22.20136309 – volume: 26 start-page: 672 issue: 5 year: 2020 ident: pcbi.1008688.ref031 article-title: Temporal dynamics in viral shedding and transmissibility of COVID-19 publication-title: Nature Medicine doi: 10.1038/s41591-020-0869-5 contributor: fullname: X He – year: 2020 ident: pcbi.1008688.ref034 article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia publication-title: New England Journal of Medicine contributor: fullname: Q Li – volume: 20 start-page: 1151 issue: 10 year: 2020 ident: pcbi.1008688.ref037 article-title: Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study publication-title: The Lancet Infectious Diseases doi: 10.1016/S1473-3099(20)30457-6 contributor: fullname: AJ Kucharski – ident: pcbi.1008688.ref040 – volume: 26 start-page: 506 issue: 4 year: 2020 ident: pcbi.1008688.ref035 article-title: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China publication-title: Nature Medicine doi: 10.1038/s41591-020-0822-7 contributor: fullname: JT Wu – ident: pcbi.1008688.ref020 doi: 10.1101/2020.03.26.20039438 – year: 2020 ident: pcbi.1008688.ref039 article-title: Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure publication-title: Annals of Internal Medicine contributor: fullname: LM Kucirka – ident: pcbi.1008688.ref044 – ident: pcbi.1008688.ref009 – ident: pcbi.1008688.ref047 doi: 10.1101/2020.08.04.20167874 – volume: 7 start-page: e48695 issue: 11 year: 2012 ident: pcbi.1008688.ref041 article-title: A nice day for an infection? Weather conditions and social contact patterns relevant to influenza transmission publication-title: PloS one doi: 10.1371/journal.pone.0048695 contributor: fullname: L Willem – ident: pcbi.1008688.ref050 – ident: pcbi.1008688.ref028 doi: 10.1101/2020.06.29.20142851 – ident: pcbi.1008688.ref027 doi: 10.1016/j.procs.2017.05.086 – ident: pcbi.1008688.ref045 doi: 10.1371/journal.pone.0243692 – volume: 37 start-page: 5525 issue: 37 year: 2019 ident: pcbi.1008688.ref049 article-title: Defining hard-to-reach populations for vaccination publication-title: Vaccine doi: 10.1016/j.vaccine.2019.06.081 contributor: fullname: S Ozawa – volume: 8 start-page: 750 issue: 8 year: 2020 ident: pcbi.1008688.ref012 article-title: Pulmonary fibrosis secondary to COVID-19: a call to arms? publication-title: The Lancet Respiratory Medicine doi: 10.1016/S2213-2600(20)30222-8 contributor: fullname: P Spagnolo – ident: pcbi.1008688.ref018 – volume: 368 start-page: 493 issue: 6490 year: 2020 ident: pcbi.1008688.ref006 article-title: The effect of human mobility and control measures on the COVID-19 epidemic in China publication-title: Science doi: 10.1126/science.abb4218 contributor: fullname: MU Kraemer – volume: 26 start-page: 1205 issue: 8 year: 2020 ident: pcbi.1008688.ref036 article-title: Age-dependent effects in the transmission and control of COVID-19 epidemics publication-title: Nature Medicine doi: 10.1038/s41591-020-0962-9 contributor: fullname: NG Davies – volume: 25 start-page: 2000062 issue: 5 year: 2020 ident: pcbi.1008688.ref030 article-title: Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2020.25.5.2000062 contributor: fullname: JA Backer – volume: 382 start-page: 1969 issue: 21 year: 2020 ident: pcbi.1008688.ref003 article-title: Developing Covid-19 vaccines at pandemic speed publication-title: New England Journal of Medicine doi: 10.1056/NEJMp2005630 contributor: fullname: N Lurie – start-page: eabd3083 year: 2020 ident: pcbi.1008688.ref052 article-title: Low-cost measurement of facemask efficacy for filtering expelled droplets during speech publication-title: Science Advances doi: 10.1126/sciadv.abd3083 contributor: fullname: EP Fischer – ident: pcbi.1008688.ref046 doi: 10.1101/2020.04.27.20078329 – ident: pcbi.1008688.ref005 doi: 10.1093/bib/bbaa232 – year: 2020 ident: pcbi.1008688.ref002 article-title: Natural History of Asymptomatic SARS-CoV-2 Infection publication-title: New England Journal of Medicine contributor: fullname: A Sakurai – ident: pcbi.1008688.ref053 doi: 10.1126/science.abc5798 – volume: 93 year: 2019 ident: pcbi.1008688.ref048 article-title: Fighting homelessness and housing exclusion in Europe publication-title: A Study of National Policies, European Social Policy Network (ESPN) contributor: fullname: I Baptista – year: 2020 ident: pcbi.1008688.ref042 article-title: False Negative Tests for SARS-CoV-2 Infection—Challenges and Implications publication-title: New England Journal of Medicine contributor: fullname: S Woloshin |
SSID | ssj0035896 |
Score | 2.5169604 |
Snippet | Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on... [...]our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the... |
SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e1008688 |
SubjectTerms | Belgium Belgium - epidemiology Biology and life sciences Compliance Computational Biology Computer Simulation Contact tracing Contact Tracing - methods Contact Tracing - statistics & numerical data Contact Tracing - trends Control Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 - transmission COVID-19 Nucleic Acid Testing - methods COVID-19 Nucleic Acid Testing - statistics & numerical data COVID-19 Nucleic Acid Testing - trends Disease transmission Epidemics Epidemics - prevention & control False Negative Reactions Family Characteristics Feasibility Feasibility Studies Households Humans Immune system Infections Mass Screening - methods Mass Screening - statistics & numerical data Mass Screening - trends Medicine and Health Sciences Model testing Models, Statistical Pandemics People and places Population Quarantine - methods Quarantine - statistics & numerical data Quarantine - trends SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Social distancing Social Sciences Telecommuting Test procedures Testing Travel Viruses |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQSkhcEN8NLMggJE6m69hJ7GMpVC0SRQKK9mb5K20llKzI7qH_npnYuzSoiAvXeOSNZyb28_r5DSGvXa3rNljNbKMck8IF5oLizDtdudgCKA_4P-Sn0_r4TH5cVstrpb6QE5bkgZPj9rkOsGb7qG3QklsFe-RWBeFlpbwObbrmu9DbzVSag0WlxspcWBSHNUIu86U50fD9HKO3K-8ukSOgUtWV34vSqN2_m6Fnqx_9cBP8_JNFeW1ZOrpH7mY8SQ_SOO6TW7F7QG6nCpNXD0mfDnVhfaKA9GgbbabDXlHbBZrYHHnCo31LL_rNEPFEimHtrRjoJhE34CfWqMeB_fQ089vp4efvJ-8Z1zSmOrN-eETOjj58OzxmucYC87Ayr5lwPDZlG0vpnCuxHtki8rDAspJttfAW9dmDs6KBYNfgbxE4zAJl5G1lvXCleExmXd_FPUKdV1LXsfSVrWTpudWeN3WUgPGcjqUuCNs62aySlIYZz9Ma2IIkbxkMislBKcg7jMTOFoWwxweQHianh_lXehTkFcbRoNRFh1yac7sZBnPy9dQcAPhqOAAU-VejLxOjN9mo7SHe3ub7CzB4lNCaWM4nlvDB-knzHubUdsyDAYgpagVICt52vs2zm5tf7pqxU-THdRESA2zwiFdxyQvyJKXlzm9CjGLUdUGaScJOHDtt6S4vRqVxVA-Ejp_-j0g8I3dK5AMhf0_PyWz9cxOfA6Bbuxfjt_sL2CZJTA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgERIXxLvbFmQQEifTdezE9gmVwtIiUSSgaG-RX2krVcnS7B7675lJnC1Bhet64k0845mJ58t8hLx2hSmqYA2zSjsmhQvMBc2ZdyZ3sYKkPOA55Jfj4vBEfl7ki3Tg1iZY5eATO0cdGo9n5HsQh0WhIdzod8tfDFmjsLqaKDRukzs8UwpfvvT80-CJRa47fi6kxmFKyEX6dE4ovpc09Xbp3TkiBXTPvXIdmroO_hs_PVleNO1NSejfWMo_gtP8Abmfskq635vBQ3Ir1o_I3Z5n8uoxafrSLkQpCvkeraJNoNgrautAe0xHcnu0qehZs24j1qUYMnDFQNc9fAP-YoVdOXCehiaUOz34-vPoA-OGxp5t1rdPyMn844-DQ5aYFpiH-LxiwvGosipm0jmXISvZLPIwQ3LJKp95i13ag7NCgcoLEyoROPiCLPIqt164TDwlk7qp4xahzmtpipj53OYy89waz1URJWR6zsTMTAkbFrlc9g01yq6qpuBFpF-tEpVSJqVMyXvUxEYW22F3PzSXp2XaXSU3ARI7H40NRnKrjVaVDsLLXHu4XZjkFeqxxIYXNSJqTu26bcuj78flPqRgikOaIv8p9G0k9CYJVQ3o29v0FQM8PDbSGknujiRh2_rR8Bba1PDMbXlt4HDlYGc3D7_cDOOkiJKrIxgGyGChV3PJp-RZb5abdROia0ldTIkaGexoYccj9flZ128cewjCxNv_v60dci9DvA_i88wumawu1_E5JGwr96Lblb8B8HdAbw priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFB7qiuCLeO_qKqMIPqXsXJLMPIjUamkFK6grfQtzS1soybrZBfffe04yCUa24OvOySSZc2bmmz1fvkPIG5vprPRGJyZXNpHC-sR6xRJndWpDCaDc4_-QX86yk4X8fJ6e75G-ZmscwGbn0Q7rSS1W1we_f23fw4R_11ZtyFl_0cHS2SvM-qtMqVvkNpdwVkcynxzyCiJVOosf0N105WiDanX8h9V6sryum11Q9F9G5V9b1PF9ci9iS3rYBcMDsheqh-ROV21y-4jUXYIX9ioKqI-WwURq7JaaytOO2REXP1qX9LLeNAGzUwnW4QqebjoSB9xijdoc2E9NI9edHn39efoxYZqGruasax6TxfGnH0cnSay3kDjYpdeJsCzkvAxcWms51iabB-bnWGKyTOfOoFa7t0bk4PhM-1J4BisCD6xMjROWiydkUtVV2CfUOiV1FrhLTSq5Y0Y7lmdBAt6zOnA9JUk_yMWyk9Uo2txaDseRbrQKdEoRnTIlH9ATgy2KYrc_1KuLIs6xgmkP8M4FbbyWzCit8lJ54WSqHDwudPIa_Vig7EWFvJoLs2ma4vT7WXEIQCxnAFbkjUbfRkZvo1FZg7-did8ywMujnNbIcjayhMnrRs37GFP9OzcFwE2RKUBV8LSzPs52N78amrFT5MpVAQIDbDDdq5hkU_K0C8th3IRohamzKclHATsa2HFLdXXZqo6jkiB0_Ow_7vuc3OVI_UGqnp6RyXq1CS8Au63ty3Y6_gFZmEYv priority: 102 providerName: Scholars Portal |
Title | Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33690626 https://www.proquest.com/docview/2513684158 https://search.proquest.com/docview/2500388141 https://pubmed.ncbi.nlm.nih.gov/PMC7943003 https://doaj.org/article/19d264ce9ad941a8987f8d3c458c9df8 http://dx.doi.org/10.1371/journal.pcbi.1008688 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2IiReJr5XKJVBSDylneN82I9tt7IhtUyDob5F_so2aUuqpX3Yf89d4lQEjRdeEqm-Oo7vzv7FPv-OkM86kUlulQxUKnQQcW0DbQULjJaxdjmAcovrkItlcnoZfVvFqz0St2dh6qB9o29Gxe3dqLi5rmMr13dm3MaJjc8XMyQ1wwW4fbIPBtp-ojfDL49FnZQL8-EEKY9W_rwcT9nYq2e0xgcgq00iMF8f5zVbb9KZmmoG_9043VvfltVjIPTvWMo_Jqf5c3LgUSWdNK1_QfZc8ZI8bfJMPrwiZbO1C7MUBbxHc6d8UOwDVYWlTUyHH_ZomdPrcls53JcKMAOXs3TbhG_AIzbIyoH1lNRHudPZ919nxwGT1DXZZk31mlzOT37OTgOfaSEwMD9vAq6ZS8PchZHWOsSsZEeO2SNMLpnHR0YhS7vViqeg8kTanFsGY0HoWB4rw3XI35BeURbukFBtRCQTF5pYxVFomJKGpYmLAOlp6ULZJ0Hbydm6IdTI6l21FD5Emt7KUD-Z10-fTFETO1mkw65_KO-vMm8UGZMWgJ1xUlkZMSWkSHNhuYliYaC5UMkn1GOGhBcFRtRcqW1VZWc_ltkEIFjKAKZE_xS66Ah98UJ5Cfo2yp9igJdHIq2O5KAjCW5rOsWHaFPtO1cZAE2eCMBT0NpBa2ePF3_cFWOlGCVXODAMkMGNXsEi1idvG7Pc9Vtr5H2Sdgy207HdEnC_mm_cu9u7__7ne_IsxFMjmEcnGZDe5n7rPgCW2-ghePAqhauYfx2SJ5Pp8XQO9-nJ8vwC7rUBD-t1ErguIjGsff03MvJRkg |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,12068,12777,21400,24330,27936,27937,31731,31732,33385,33386,33756,33757,38528,43322,43612,43817,43907,53804,53806,74073,74363,74630,74740 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegCMHLxPc6BhiExJNZHTuJ_YTGoLSwFQk21LfIX9kmoaQs7cP-e-4StyNo8Fpf3cR3vrv6fr4fIa9tprPSG81MriyTwnpmveLMWZ3aUEJS7vEc8miWTU7k53k6jwduTYRVrn1i66h97fCMfA_isMgUhBv1bvGLIWsUVlcjhcZNcksKiNV4U3z8ae2JRapafi6kxmG5kPN4dU7kfC9q6u3C2XNECqiOe-UqNLUd_Dd-erD4WTfXJaF_Yyn_CE7je2QrZpV0vzOD--RGqB6Q2x3P5OVDUnelXYhSFPI9WgYTQbGX1FSedpiO6PZoXdKzetUErEsxZOAKnq46-Ab8xBK7cuA8NY0od3rw9cf0A-Oaho5t1jWPyMn44_HBhEWmBeYgPi-ZsDzkSRkSaa1NkJVsFLgfIblkmY6cwS7t3hqRg8oz7UvhOfiCJPAyNU7YRDwmg6quwjah1imps5C41KQycdxox_MsSMj0rA6JHhK2XuRi0TXUKNqqWg5_RLrVKlApRVTKkLxHTWxksR12-0F9cVrE3VVw7SGxc0EbryU3Squ8VF44mSoHjwuTvEI9FtjwokJEzalZNU0x_T4r9iEFyzmkKfKfQt96Qm-iUFmDvp2Jtxjg5bGRVk9ytycJ29b1hrfRptbv3BRXBg7fXNvZ9cMvN8M4KaLkqgCGATJY6FVc8iF50pnlZt2EaFtSZ0OS9wy2t7D9ker8rO03jj0EYeKd_z_WC3Jncnx0WBxOZ1-ekrsJYn8Qq6d3yWB5sQrPIHlb2uftDv0N-nFDUQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1db9MwFLWgE4gXvmGFAQYh8ZS2jp3EfkJjY1r5KAgY6lvkr2zTUFKW9mH8eu5NnI5Mgyde61s3sa-vT-OTcwh5aVKVFk6rSGfSRIIbFxknWWSNSowvAJQ7fA75cZbuH4h382Qe-E91oFV2NbEp1K6y-Ix8DPswTyVsN3JcBFrE592914ufETpI4UlrsNO4SjYAIovJgGzsfPo-3e3qMk9k49aFRjlRxsU8vEjHMzYO8zZaWHOMvAHZOrGcb1SNnv-6ag8WP6r6Mkh6kVn5x1a1d4ucdDfZMlRORqulGdlfF_Qf_88o3CY3A6Kl220K3iFXfHmXXGs9Ls_ukao9VoYdkgLWpIXXgZB7RnXpaMsnCSWXVgU9qla1xzOxCN2_vKOrljoCP7FERRDsp6KBYU-bsY-Yor51urX1fXKw9_bbzn4UXB4iC9hgGXHDfBYXPhbGmBgd0SaeuQkaWxbJxGpUiHdG8wzSLVWu4I5BHYo9KxJtuYn5AzIoq9JvEmqsFCr1sU10ImLLtLIsS70AlGmUj9WQRN2U5otWzCNvTvQy-BPUjlaOKZCHFBiSNzjv61iU4m4-qE4P87Cyc6YcgErrlXZKMC2VzArpuBWJtHC50MkLzJocxTZKnLBDvarrfPp1lm8D_MsYQCTx16AvvaBXIaioILusDm9QwM2jiFcvcqsXCSXD9po3MYO7e67z87SCb3aJd3nz83UzdooMvdJDYkAMHjJLJtiQPGwXwXrcOG_ksNMhyXrLozew_Zby-KjROkf9Quj40b8v6xm5Dssg_zCdvX9MbsRIO0KaoNoig-Xpyj8B3Lg0T0NB-A29BXBg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessing+the+feasibility+and+effectiveness+of+household-pooled+universal+testing+to+control+COVID-19+epidemics&rft.jtitle=PLoS+computational+biology&rft.au=Libin%2C+Pieter+J+K&rft.au=Willem%2C+Lander&rft.au=Verstraeten%2C+Timothy&rft.au=Torneri%2C+Andrea&rft.date=2021-03-09&rft.eissn=1553-7358&rft.volume=17&rft.issue=3&rft.spage=e1008688&rft.epage=e1008688&rft_id=info:doi/10.1371%2Fjournal.pcbi.1008688&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7358&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7358&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7358&client=summon |